LeadIQ logo
Learn more at LeadIQ.com

Insights

Key Personnel Update iTeos Therapeutics appointed David Feltquate, an experienced Chief Medical Officer, indicating strong leadership to drive strategic partnerships and therapeutic advancements.

Significant Financial Backing Recent investments totaling over $1.16 million showcase investor confidence in iTeos Therapeutics, potentially enabling capital influx for business expansion and R&D efforts.

Strategic Funding Infusions Receiving financing of $625 million demonstrates a robust financial position, positioning iTeos Therapeutics for strategic acquisitions, innovative drug development, and market penetration.

Tech-Driven Competitive Edge Leveraging a tech stack including Google Analytics, SAP, and Cloudflare, iTeos Therapeutics is poised to harness data insights for targeted marketing strategies and enhanced customer engagement.

Market Expansion Potential With a revenue range of $10-50 million and a focused industry on immuno-oncology, iTeos Therapeutics stands as a promising player for collaborative efforts with similar companies in the biotechnology research space.

iTeos Therapeutics Tech Stack

iTeos Therapeutics uses 8 technology products and services including Google Analytics, Cloudflare, SAP, and more. Explore iTeos Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Cloudflare
    Content Management System
  • SAP
    Customer Relationship Management
  • Microsoft 365
    Email
  • web-vitals
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Yoast SEO
    Search Engines
  • Cloudflare Bot Management
    Security

Media & News

iTeos Therapeutics's Email Address Formats

iTeos Therapeutics uses at least 1 format(s):
iTeos Therapeutics Email FormatsExamplePercentage
First.Last@iteostherapeutics.comJohn.Doe@iteostherapeutics.com
95%
Last@iteostherapeutics.comDoe@iteostherapeutics.com
3%
First.Middle@iteostherapeutics.comJohn.Michael@iteostherapeutics.com
1%
First.MiddleLast@iteostherapeutics.comJohn.MichaelDoe@iteostherapeutics.com
1%

Frequently Asked Questions

Where is iTeos Therapeutics's headquarters located?

Minus sign iconPlus sign iconiTeos Therapeutics's main headquarters is located at 139 Main Street Cambridge, Massachusetts 02142 US. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is iTeos Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact iTeos Therapeutics's main corporate office by phone at
+32-71-91-9****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is iTeos Therapeutics's stock symbol?

Minus sign iconPlus sign iconiTeos Therapeutics is a publicly traded company; the company's stock symbol is ITOS.

What is iTeos Therapeutics's official website and social media links?

Minus sign iconPlus sign iconiTeos Therapeutics's official website is iteostherapeutics.com and has social profiles on LinkedIn.

How much revenue does iTeos Therapeutics generate?

Minus sign iconPlus sign icon As of November 2024, iTeos Therapeutics's annual revenue reached $35M.

What is iTeos Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconiTeos Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does iTeos Therapeutics have currently?

Minus sign iconPlus sign iconAs of November 2024, iTeos Therapeutics has approximately 186 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: P. G.Chief Medical Officer: D. F.Chief Operating Officer: M. C.. Explore iTeos Therapeutics's employee directory with LeadIQ.

What industry does iTeos Therapeutics belong to?

Minus sign iconPlus sign iconiTeos Therapeutics operates in the Biotechnology Research industry.

What technology does iTeos Therapeutics use?

Minus sign iconPlus sign iconiTeos Therapeutics's tech stack includes Google AnalyticsCloudflareSAPMicrosoft 365web-vitalsOpen GraphYoast SEOCloudflare Bot Management.

What is iTeos Therapeutics's email format?

Minus sign iconPlus sign iconiTeos Therapeutics's email format typically follows the pattern of . Find more iTeos Therapeutics email formats with LeadIQ.

How much funding has iTeos Therapeutics raised to date?

Minus sign iconPlus sign icon As of November 2024, iTeos Therapeutics has raised $120M in funding. The last funding round occurred on May 10, 2024 for $120M.

When was iTeos Therapeutics founded?

Minus sign iconPlus sign iconiTeos Therapeutics was founded in 2011.
iTeos Therapeutics

iTeos Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT/CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.

Section iconCompany Overview

Headquarters
139 Main Street Cambridge, Massachusetts 02142 US
Phone number
+32-71-91-9****
Website
iteostherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ITOS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $120M

    iTeos Therapeutics has raised a total of $120M of funding over 9 rounds. Their latest funding round was raised on May 10, 2024 in the amount of $120M.

  • $10M$50M

    iTeos Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $120M

    iTeos Therapeutics has raised a total of $120M of funding over 9 rounds. Their latest funding round was raised on May 10, 2024 in the amount of $120M.

  • $10M$50M

    iTeos Therapeutics's revenue is in the range of $10M$50M

Company Leadership

  • Stylized image of a person
    P. G.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. F.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. C.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. K.
    Chief Medical Officer (interim)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Chief Financial Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    M. G.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Y. M.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. J.
    Chief Information Security Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. G.
    Chief Executive Officer
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.